FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk
Last month, Frito-Lay issued a recall warning that more than 6,300 of its 13-ounce bags may contain undeclared milk posing a ...
MedPage Today6d
FDA Warns About Anaphylaxis Risk With MS Drug
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
Healio6d
FDA issues anaphylaxis warning on multiple sclerosis treatment
The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...
What’s the difference between a food allergy and an intolerance?
You can have a reaction to various foods, but it’s not always an allergy – the difference lies with your immune system.
Allergy Treatment Market Size is Projected to Reach USD 64.65 billion by 2033, Growing at a CAGR of 6.46%: Straits Research
The global allergy treatment market size was valued at USD 34.57 Billion in 2024 and is projected to reach from USD 36.80 ...
The American Journal of Managed Care6d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
Monthly Prescribing Reference4d
FDA: Anaphylaxis Risk Prompts Boxed Warning for MS Drug
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.